Related Experiment Video

Updated: Jun 16, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Stem cell therapy in PAD

R W Sprengers1, F L Moll, M C Verhaar

  • 1Department of Vascular Surgery, Utrecht, The Netherlands. r.w.sprengers@umcutrecht.nl

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|February 16, 2010
PubMed

Insights

Critical limb ischemia (CLI) is a major health issue, with many patients ineligible for current treatments. Growth factor and stem cell therapies show promise for improving blood vessel growth and preventing amputation in CLI patients.

Area of Science:

  • Vascular Biology and Regenerative Medicine

Background:

  • Critical limb ischemia (CLI) presents a significant healthcare challenge, often leading to amputation for patients unsuitable for revascularization.
  • Current treatment options for CLI are limited, particularly for those deemed 'no-option'.

Purpose of the Study:

  • To explore the potential of growth factor and stem cell therapies for augmenting postnatal neovascularization in CLI.
  • To highlight the need for further research into the mechanisms of neovascularization and clinical trials for CLI treatment.

Main Methods:

  • Review of pre-clinical and clinical results for growth factor and stem cell therapies in CLI.
  • Discussion of the current understanding of postnatal neovascularization mechanisms.

Main Results:

  • Growth factor and stem cell therapies demonstrate promise in promoting neovascularization.
  • These therapies may reduce CLI symptoms and potentially prevent amputations.

Conclusions:

  • Further fundamental research and large randomized trials are essential for optimizing neovascularization therapies for CLI.
  • Advances in these regenerative approaches could significantly improve outcomes for 'no-option' CLI patients.

More Related Videos

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

Use of Human Perivascular Stem Cells for Bone Regeneration07:05

Use of Human Perivascular Stem Cells for Bone Regeneration

Published on: May 25, 2012

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...